Advancing Biologics to Transform Cancer Treatment
Aarvik Therapeutics is pursuing exciting molecules with an improved therapeutic index for several oncology targets by combining novel modular antibody platforms with multiple target mechanisms.
Aarvik antibody platforms are readily manufacturable, scalable and versatile, and offer unlimited potential through modular design.
